Previous Article | Next Article 
Infection and Immunity, July 1999, p. 3383-3389, Vol. 67, No. 7
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Isolation of T-Cell Antigens by Using a Recombinant
Protein Library and Its Application to the Identification of Novel
Vaccine Candidates against Schistosomiasis
Matthias
Eberl,1,2,*
Adrian P.
Mountford,2
Dragana
Jankovic,3 and
Ewald
Beck1
Biochemisches Institut,
Justus-Liebig-Universität Giessen, 35392 Giessen,
Germany1; Department of Biology,
University of York, York YO10 5YW, United
Kingdom2; and Laboratory of Parasitic
Diseases, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Bethesda, Maryland
208923
Received 20 November 1998/Returned for modification 5 January
1999/Accepted 15 April 1999
 |
ABSTRACT |
We present here a novel approach to identify T-cell antigens from
any infectious agent by use of a library of purified recombinant proteins. Essential features of this strategy include (i) a highly efficient cDNA cloning system which negatively selects against nonrecombinant transformants by making use of the bacterial
EcoK restriction system, (ii) affinity staining of cDNA
clones expressing recombinant proteins, and (iii) a procedure of
simultaneous purification of recombinant proteins from large numbers of
isolated clones (representing the protein library) in a single step
from pools consisting of up to 24 individual clones. The feasibility of
the screening system was confirmed by constructing a protein library of
the human parasite Schistosoma mansoni. The recombinant
antigens of this library were used to stimulate CD4+ T
cells derived from the axillary lymph nodes of mice vaccinated with
irradiated cercariae. In initial screening experiments, we detected
parasite-specific proliferation and gamma interferon (IFN-
)
secretion in response to several pools of cDNA clones. Further analysis
of one particular pool revealed that only one of its constituents
stimulated considerable IFN-
secretion by CD4+ T cells
and that the expressed antigen is identical to a small fragment of
myosin heavy chain.
 |
INTRODUCTION |
Over the last few years,
cell-mediated immune responses have been shown to be responsible for
protective immunity against a wide range of parasites and intracellular
bacteria (10). Consequently, identification of the
corresponding T-cell epitopes in these models represents a pivotal step
in the design of new and effective vaccines.
Several groups have already managed to clone potent T-cell antigens
from various organisms. Conventionally, these recombinant antigens have
been identified by screening cDNA expression libraries with sera from
infected patients (24, 34), sera from experimentally exposed
animals (2), or sera raised against biochemically
fractionated antigens from the infective pathogen (11). The
selected cDNA clones were subsequently tested for their
T-cell-stimulatory capacities. However, this combination of
antibody-based screening and T-cell assays permits the identification
only of T-cell antigens, which also carry B-cell epitopes on the same
molecule (18). Alternatively, crude supernatants
(31) or semipurified fusion proteins (30) from
bacteriophage expression libraries have been used directly in T-cell
proliferation assays, thereby avoiding screening with antisera.
However, only soluble antigens may be identified by these techniques
(34), while many recombinant proteins form insoluble
aggregates (27). Furthermore, in most screening assays only
T-cell clones (9, 14, 20) or T-cell hybrids (22) have been used as responder cells. This might be due to the easy availability of large homogeneous cell populations from cultivated cell
lines, and it also avoids background stimulation of non-T cells in
heterogeneous cell populations by bacterial endotoxin contamination of
crude antigen preparations. None of these strategies mentioned above
has proven to be applicable to routine work. Even more important, there
is no standardized method available for screening a whole cDNA library
solely on the basis of T-cell reactivity that is applicable to
polyclonal cell populations from lymph nodes (LN), blood, or spleen for
systematic identification of the relevant T-cell antigens of a given pathogen.
We present here a novel screening approach which allows simultaneous
expression and affinity purification of large numbers of randomly
selected recombinant proteins from any organism suitable for
stimulation studies with T cells. The antigens of the so-called protein
library can be easily copurified from pools consisting of up to 24 different clones and then tested with lymphocytes derived from infected
or immunized hosts. We demonstrated the feasibility of our approach by
the construction of a Schistosoma mansoni protein library,
leading to the identification of a fragment of myosin heavy chain as a
highly reactive T-cell epitope in mice vaccinated with irradiated cercariae.
 |
MATERIALS AND METHODS |
Animals and parasites.
NMRI, MF1, and C57BL/6 mice were
obtained from the breeding facilities of the Biochemisches Institut,
Justus-Liebig-Universität Giessen, Giessen, Germany, and the
Department of Biology, University of York, York, United Kingdom. Puerto
Rican isolates of S. mansoni were maintained by passage
through NMRI or MF1 mice and Biomphalaria glabrata snails.
Infections were performed percutaneously by standard techniques
(25). Soluble worm antigens (SWAP) were prepared as
previously described (16).
Construction of the vector plasmid.
Incubations with
DNA-modifying enzymes were performed according to the instructions of
the manufacturer (New England Biolabs or Promega). DNA sequences were
determined by standard techniques. Synthetic oligonucleotides were
purchased from Pharmacia. The EcoK recognition sequence
within the ampicillin resistance gene of pQE-12 (Qiagen) was destroyed
by site-directed PCR mutagenesis without changing the amino acid
sequence of the encoded
-lactamase enzyme. After filling in of the
original EcoRI site in the promoter region, the
oligonucleotides AATTAACGAATTCGTGCTA and
AATTTAGCACGAATTCGTT were inserted between the
BamHI and HindIII sites of the vector, thus
forming a new cloning site. Cloning steps were performed in
Escherichia coli TG1 (EcoK negative) in order to
obtain EcoK-unmethylated plasmid DNA.
Preparation of cDNA.
A
gt10 cDNA library from adult
S. mansoni was constructed by standard protocols
(21). Second-strand cDNA synthesis was performed with random
(N6) primers as well as with oligo(dT) primers. Phage DNA
was purified from a plate lysate of the whole library by affinity
chromatography (Qiagen), and cDNA inserts were PCR amplified. For each
reaction, 0.25 µg of
gt10 DNA template, 25 pmol of primers, 250 µM deoxynucleoside triphosphates, 2.5 mM MgCl2, and 3 U
of Taq polymerase (Promega) were used in a total volume of
50 µl. Cycles were 94°C for 30 s, 60°C for 1 min, and 72°C
for 2 min, with 20 repeats. Purification and desalting of the amplified
cDNA were performed on S-500 columns (Pharmacia). Fractions with
apparent fragment sizes of between 200 and 3,000 bp were pooled and
digested with EcoRI.
The protein library.
PCR-amplified cDNA was inserted into
the EcoRI restriction site of pEcoK-5 and introduced into
E. coli M15 (EcoK positive). For each reaction,
0.01 pmol of unmethylated plasmid DNA and 1 to 2 µg of purified cDNA
were ligated. Screening for cDNA-containing colonies was performed by
PCR analysis of randomly isolated clones. Screening for antigen
expression was performed by colony blotting onto nitrocellulose
membranes with an Ni-nitrilotriacetic acid (NTA)-alkaline phosphatase
conjugate according to the instructions of the manufacturer (Qiagen).
Positive colonies were picked from the original bacterial plates and rescreened.
Subcloning of calpain and FABP cDNAs.
The cDNA of
schistosome calpain (accession no. M67499) was subcloned by inserting
the EcoRI/BglII fragment of plasmid pRizk1C (1) into a derivative of pEcoK-5. The 280-amino-acid
fragment expressed by pDS-calpain/EB contained the T-cell epitope
recognized by the previously described Th1 cell clone B (9).
Plasmid pDS-FABP, expressing the complete coding sequences of fatty
acid binding protein (FABP) (Sm14; accession no. M60895), was described elsewhere (13).
Purification of recombinant antigens.
For individual
recombinants, bacterial broth was inoculated 1:10 with overnight
cultures of the respective E. coli cDNA clones. For
preparation of antigen pools, up to 50 separately grown overnight cultures of cDNA clones from the protein library were mixed and diluted
1:10 with bacterial broth. After 30 min, protein expression was induced
by treatment with 2 mM
isopropyl-
-D-thiogalactopyranoside for 3 to 4 h.
Bacterial cells were pelleted and lysed in 6 M guanidine hydrochloride-100 mM Na2HPO4, pH 8.0. TALON
affinity matrix (Clontech) was added to the supernatant and after
1 h was washed three times with 8 M urea-100 mM
Na2HPO4-50 mM NaCl at pH 8.0 and once with the
same solution at pH 7.5. Elution of recombinant antigens was performed
by addition of 50 mM EDTA. Eluted individual or pooled antigens were
analyzed for purity and molecular mass on Tricine-sodium dodecyl
sulfate gels (23). Protein concentrations were determined by
a bicinchoninic acid protein assay (Pierce), and samples were dialyzed
against phosphate-buffered saline (PBS) or culture medium.
T-cell proliferation and cytokine assays.
C57BL/6 mice (6 to
8 weeks old) were vaccinated via the shaved abdomen with 500 S. mansoni cercariae attenuated by 20 krads of irradiation with the
60Co source at the Strahlenzentrum, Universität
Giessen, Germany, or at Cookridge Hospital, Leeds, United Kingdom. On
day 4 after immunization, single-cell suspensions of the axillary LN
were prepared, and the pooled LN cells from 10 mice were incubated with
CD4+ magnetic beads and separated on VS+ MACS
columns (Miltenyi). Eluted cell populations were 92 to 97% CD4+, as determined by flow cytometry with
CD4+-fluorescein isothiocyanate antibodies (Pharmingen).
Splenocytes from naive mice were irradiated with 3,000 rads and used as
antigen-presenting cells (APC) for CD4+ populations. A
total of 1 × 105 LN cells alone or 1 × 105 CD4+ cells with 4 × 105
APC were cultivated in 96-well plates in 200 µl/well as described previously (15). Cultures were stimulated with soluble
antigens and with individual or pooled recombinant antigens as
indicated in the figure legends. After 72 h, 120 µl of
supernatant was removed and tested for the presence of gamma interferon
(IFN-
) and interleukin-4 (IL-4) by corresponding two-site
enzyme-linked immunosorbent assays (ELISAs) as described previously
(16). Cells were pulsed with [3H]thymidine
(18.5 kBq per well; ICN) and harvested 18 h later. Isotope
incorporation was determined by liquid scintillation counting.
The calpain-specific Th1 cell clone B was maintained and used for
stimulation assays as described previously (9). In brief, once the clone was established, it was stimulated every 3 to 4 weeks
with antigen and APC. During the intervening period, it was expanded in
medium supplemented with 35 U of recombinant human IL-2 (generously
provided by Cetus Corp., Emeryville, Calif.) per ml. For proliferation
assays and cytokine analysis, resting clone B cells were incubated at
2 × 105 cells/well with 5 × 105 APC
in a final volume of 200 µl in the presence of antigen, as indicated
in the figure legends. Supernatants were removed for IFN-
determination after 48 h. Proliferation was measured by overnight
incorporation of [3H]thymidine.
ELISA.
Multiple-vaccination serum was obtained from a
C57BL/6 mouse exposed three times to irradiated cercariae 14 days after
the third vaccination. Microtiter plates (Maxisorp; Nunc) were coated overnight at 4°C with recombinant IrV-5 (kindly provided by Karl Hoffmann) or clone 2.3 at 4 µg/ml (50 µl/well) diluted in PBS. The
plates were washed five times with PBS plus 0.05% Tween 20 (PBST) and
probed for 2 h at room temperature with the serum samples diluted
1:100 in PBST (50 µl/well). After five washes, the plates were probed
for 2 h at room temperature with peroxidase-labelled rabbit
anti-mouse immunoglobulin G (Sigma) diluted 1:2,000 in PBST. After a
further five washes, 50 µl of 3,3',5,5'-tetramethylbenzidine substrate solution (Kirkegaard & Perry Laboratories) was added to each
well. Fifteen minutes later, absorbance was quantified at 630 nm with a
Dynatech MR500 ELISA reader.
 |
RESULTS |
Construction of a vector for highly efficient cDNA cloning.
The cDNA inserts of a previously constructed library of adult S. mansoni worms in bacteriophage
gt10 (EB) were PCR amplified and
ligated into plasmid pEcoK-5. This plasmid is a derivative of
expression vector pQE-12 (Qiagen) and was designed to allow positive
selection of recombinant clones by means of the bacterial EcoK restriction system. The original EcoRI site
in the promoter region and the EcoK signal in the ampicillin
resistance gene of pQE-12 were destroyed, and a new EcoRI
cloning site, flanked by the two motifs of the new EcoK
recognition sequence, was created between the BamHI and
HindIII sites of the multiple cloning site (Fig.
1). After insertion of cDNA, the
EcoK signal is destroyed, thus allowing replication of the
recombinant plasmid while restricting the wild-type vector (7,
32). By using unmethylated plasmid DNA for insertion of
heterogeneous PCR-amplified schistosome cDNA, up to 84% of all
colonies contained cDNA inserts upon transformation of
EcoK-positive bacteria (E. coli M15), whereas the
EcoK-negative E. coli strain TG1 yielded only 5 to 6% recombinants (Table 1).

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 1.
Essential features of the cloning and expression vector,
pEcoK-5. Heterogeneous PCR-amplified cDNA was inserted into a unique
EcoRI site flanked by the recognition motifs of the
EcoK restriction system (the original EcoK signal
in the ampicillin resistance (ampR) gene was destroyed
previously without changing the amino acid sequence of the encoded
enzyme). Clones expressing recombinant antigens could easily be
identified and isolated after detection of the N-terminal histidine
tags fused to each protein.
|
|
Creation of a recombinant protein library.
Colonies stably
expressing inserted open reading frames could easily be identified by
use of an Ni-NTA conjugate covalently linked to alkaline phosphatase
(Qiagen). This complex bound specifically to the N-terminal histidine
residues of the recombinant proteins. Selective staining of recombinant
fusion proteins by the Ni-NTA conjugate is possible due to the fact
that small histidine-tagged peptides, up to ca. 30 amino acids in
length, resulting from cDNAs inserted in inverse orientation or in the
wrong reading frame are quickly degraded in the bacteria (Qiagen). By
colony blotting, we obtained approximately 6 to 9% positively stained
colonies after cDNA transformation, all of which expressed recombinant antigens as verified by protein analysis of isolated clones. The molecular masses of the expressed antigens ranged between 2 and 45 kDa,
whereas the cDNA insert sizes ranged from ca. 100 to more than 2,000 bp, as determined by PCR analysis (data not shown). A total of 960 cDNA
clones were isolated and stored in microwell plates. Sequence analysis
of 96 randomly chosen cDNA clones revealed the presence of large
proportions of schistosome-specific sequences (33.8% of all cDNA
inserts) as well as unknown sequences (43.2%) in the protein library,
while their redundancy was quite low. Among the schistosome proteins
identified were cathepsin B, tropomyosin, FABP, and cyclophilin B. Large numbers of recombinant antigens were expressed in pools
consisting of up to 24 different individual clones and purified with
TALON affinity matrix (Clontech). After copurification, gel
electrophoresis revealed that distinct protein bands could be observed
for each of the clones, with different band intensities according to
the expression levels and the growth rates of the individual cDNA
clones (Fig. 2).

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 2.
Recombinant antigens purified from 960 randomly isolated
cDNA expression clones of the S. mansoni protein library.
For each of the 40 lanes, 24 cultures were pooled randomly. Protein
purification of these pools were performed by using TALON affinity
matrix (Clontech) under denaturing conditions. The amount of protein
per lane corresponds to 4 ml of bacterial culture. Lane m, protein size
markers (in kilodaltons).
|
|
Stimulation of CD4+ cells from vaccinated mice with
recombinant antigens.
SWAP stimulated proliferation and cytokine
synthesis of LN cells (Fig. 3A) and
CD4+ populations (Fig. 3B and C) derived from mice
vaccinated with irradiated cercariae but not from naive animals.
Consistent with results of previous experiments showing induction of
Th1-type immune responses after vaccination with radiation-attenuated
larvae (16), the production IFN-
was much higher than of
IL-4 (data not shown). Of the two recombinant schistosome antigens,
FABP and calpain, tested, only calpain stimulated high levels of LN cell and CD4+-T-cell activity (Fig. 3). Levels of
proliferation and cytokine production for preparations from bacteria
transformed with the empty cloning vector, pEcoK-5, were always
indistinguishable from values obtained with medium alone, thus
indicating the absence of detectable mitogenic contamination in the
recombinant protein samples. In this study, 264 recombinant antigens
from the S. mansoni protein library were copurified into 22 different pools, each containing 12 cDNA clones. We observed highly
significant stimulation of T cells in the presence of some pools
(>4.5-fold-increased levels of IFN-
secreted by CD4+
cells for pool 2 and two other pools), whereas others showed no signals
at all (pool 7 and four other pools), despite the presence of similar
protein amounts in the preparations (Fig. 3). The remaining pools
induced intermediate responses, with IFN-
levels increased to 1.5- to 3.5-fold above background values (data not shown).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 3.
Stimulation of murine lymphocytes with recombinant
antigens. (A) IFN- production by unfractionated LN cells. (B)
Proliferation of purified CD4+ cells. (C) IFN-
production by CD4+ cells. Axillary LN cells from naive
(light bars) and vaccinated (dark bars) mice were cultivated with
medium alone or in the presence of 15 µg of SWAP per ml. FABP and
calpain were used at 10 µg/ml. A total of 264 antigens derived from
the protein library were purified into 22 pools, each containing 12 randomly isolated cDNA clones. These were used for stimulation assays
at concentrations corresponding to ca. 4 ml of bacterial culture per
well (final antigen concentrations of about 10 to 50 µg/ml). The
results shown for pools 2 and 7 represent typical results for different
pools. Bacteria carrying the empty cloning vector, pEcoK-5, were
included in the purification protocol to check for copurified bacterial
contamination. The data represent the mean values of stimulation assays
performed in triplicate.
|
|
Stimulation of CD4+ cells with mixtures of calpain and
FABP.
Since recombinant FABP did not elicit any cellular response
at all, it was used as a negative control in further experiments. To
evaluate if specific T-cell responses (i.e., to calpain) can be
observed even in the presence of a large excess of irrelevant antigens
(i.e., FABP), calpain and FABP were copurified from pooled bacterial
cultures after inoculation with the cDNA expression clones at ratios
ranging from 100:1 to 1:100. These mixtures were used at equal
dilutions to stimulate the calpain-specific T-cell clone B and freshly
isolated CD4+ cells from vaccinated mice. In both cases,
calpain-induced IFN-
was detectable even at a 100-fold excess of
FABP when compared to the negative control with FABP alone (Fig.
4). It should be noted that due to the
lower expression level of the calpain cDNA clone, the resulting ratio
of calpain to FABP in the T-cell assays was even lower than the
theoretically expected value of 1:100. Therefore, these results
indicate that it should be possible to screen pools of cDNA clones each
containing even more than the 12 clones used in the above-described
experiments (Fig. 3).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 4.
Stimulation of T cells with mixtures of recombinant
antigens. (A) IFN- production by the calpain-specific Th1 clone B. (B) IFN- production by CD4+ cells from the LN of
vaccinated mice. Calpain and FABP were copurified after cocultivation
of both expression cDNA clones at different ratios, ranging between
100:1 and 1:100. Antigens were used at dilutions corresponding to 3.5 ml of bacterial culture per ml. Due to different levels of expression
of these cDNA clones, final antigen concentrations ranged from 6.7 µg/ml (calpain control) to 22.0 µg/ml (FABP control), with the
mixtures in between.
|
|
Stimulation of CD4+ cells by a fragment of myosin heavy
chain.
Since pool 2 antigens induced IFN-
secretion from
CD4+ cells at levels comparable to SWAP or recombinant
calpain, the identities of the cDNA clones contained in this pool were
investigated further. After expression and purification of the 12 individual antigens, clone 2.3 in particular exhibited high levels of
IFN-
secretion by CD4+ cells from vaccinated mice (Fig.
5), whereas cells from naive mice showed
no stimulation at all. IFN-
production was also induced to a lesser
extent by clones 2.2, 2.6, and 2.10. The importance of these three
clones as candidate T-cell antigens remains to be confirmed. DNA
sequence analysis revealed that the cDNA insert of clone 2.3 was
identical to a 178-bp fragment of schistosome myosin heavy chain
(33). Interestingly, the 62-kDa IrV-5 fragment of myosin
heavy chain has previously been associated with protective immunity in
the radiation-attenuated vaccine model (26). It should be
noted, however, that the sequences of clone 2.3 and IrV-5 do not
overlap except in two codons (Fig. 6).
The individual cDNA clones of several other pools showing positive
effects on T cells are currently being analyzed, and there might be
further T-cell epitopes present among the 264 cDNA clones screened so far.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 5.
Stimulation of CD4+ cells from naive (light
bars) and vaccinated (dark bars) mice with the 12 individual antigens
of pool 2. The protein amounts corresponded to 0.2 ml of bacterial
culture per well. Negative control ( ), medium alone; positive control
(+), 10 µg of calpain per ml. The data represent the mean values of
stimulation assays performed in triplicate.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 6.
Alignment of the DNA sequence of myosin heavy chain
(accession no. L01634) with those of the cloned fragments IrV-5
(accession no. X65591) and cDNA clone 2.3. The positions of the first
and the last base pairs within the 6,969-bp myosin sequence are shown.
The coding region of myosin ranges from bp 121 to 5943.
|
|
Antibody reactivity to clone 2.3.
Consistent with the fact
that multiple exposures to the irradiated vaccine induce a specific
antibody response against the IrV-5 fragment (26), in an
ELISA experiment the multiple-vaccination serum strongly recognized
IrV-5 but only marginally recognized clone 2.3 (Fig.
7). A Western blot of recombinant IrV-5,
as well as calpain, gave a strong signal when probed with serum from a multiply vaccinated mouse (data not shown). However, this serum did not
recognize the clone 2.3 protein. Furthermore, by colony blotting we
could not detect clone 2.3 with this serum, although the calpain
expression clone, pDS-calpain/EB, was readily detected (data not
shown).

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 7.
Antibody reactivity to clone 2.3 (dark bars) and IrV-5
(light bars). Antisera were obtained from naive mice or after three
exposures to irradiated cercariae (3× vacc.). The data represent the
mean values and standard errors of assays performed in duplicate. OD,
optical density.
|
|
 |
DISCUSSION |
We here report the first screening protocol for identification of
T-cell antigens, combining high-level expression of recombinant antigens with an application to heterogeneous T-cell populations, thus
providing the technology for the development of powerful vaccines. Our
new strategy is based on the production of libraries containing
hundreds, or thousands, of proteins of an organism and on the use of
these purified proteins for T-cell proliferation and cytokine assays.
In contrast to previously published methods (9, 14, 20), our
protocol allows the use of polyclonal T-cell populations from infected
or immunized hosts for stimulation assays, i.e., without prior
establishing T-cell clones or T-cell lines. This method was used to
identify T-cell antigens in mice vaccinated against schistosomiasis,
where the protective immune response depends on the presence of
antigen-specific CD4+ T cells (6). However, the
screening system described should be applicable to any other model of
infectious diseases where cell-mediated immune responses play a key
role, such as murine leishmaniasis in resistant mice (4) or
Listeria infections (29). Furthermore, it also is
pertinent to CD4+-T cell-dependent reactions in autoimmune
diseases, tumor immunology, allogeneic transplantations, and allergic
reactions (12, 19).
Although they are indispensable for construction of comprehensive cDNA
libraries, conventional bacteriophage vectors are not appropriate for
large-scale production of individual recombinant proteins.
Plasmid-based expression systems are more suitable in this respect
(27). However, they have the disadvantage of depending upon
large quantities of cDNA for library construction due to the low
transformation efficiency of naked DNA. In order to construct a
powerful protein expression library, the positive features of both
vector systems were combined. Because of the limited amounts of
parasite material, adult schistosome cDNA was PCR amplified from a
phage library, although we are aware that PCR amplification of
heterogeneous cDNA might bias the original content of the library. In
this respect, to avoid as far as possible PCR-related changes in the
original frequency of certain transcripts, as well as to minimize the
likelihood of point mutations, we restricted the reaction to a maximum
of 20 PCR cycles. Short cDNA fragments with only little sequence
information were removed by gel filtration. To increase the yield of
recombinant plasmids, EcoK restriction was used as a
positive-selection system (Fig. 1). Consistent with the results of
others (7, 32), this led to an enrichment of cDNA-positive
clones by a factor of 16 compared with the transformation of
EcoK-negative cells (Table 1). Moreover, the total yields of
cDNA-positive colonies of up to 84% in our hands were even higher than
those described previously (7, 32). In contrast to most
other vector systems (5), here only a minimum of
vector-encoded sequences was added to the inserted parasite cDNA. There
were just 10 additional amino acids, including a tag of 6 histidine residues, at the N terminus of each recombinant antigen and translation stops in every reading frame two to five codons behind the inserted cDNA.
Prior selection of individual protein-expressing cDNA clones by
histidine tag-specific staining was performed, since the cDNA was
inserted in a random orientation into the plasmid. Therefore, only one
of six clones could statistically contain cDNA inserted in the correct
reading frame. In order to keep bacterial contamination at a minimum,
antigen-expressing cDNA clones were initially selected from the excess
of unproductive clones of the primary gene library by using an
Ni-NTA-alkaline phosphatase conjugate. The selection procedure
eliminates clones containing very short translation products because
they are degraded by an intrinsic proteolytic activity in E. coli. Conventionally, in order to reduce the total numbers of cDNA
clones to be analyzed, preselection of immunogenic epitopes has been
performed by screening cDNA libraries with immune sera (9,
20). In contrast, preselection of antigen-expressing clones with
a biochemical affinity matrix as described in our work is a novel
method which avoids the need for specific antibodies and therefore
allows the creation of expression libraries also containing antigens
that are not recognized by any serum.
By isolation of individual cDNA clones to build up a protein library,
expression of randomly isolated antigens could be performed in a
controlled and reproducible manner, which is in contrast to a protocol
described by Mougneau and colleagues (14). Sequential fractionation and rescreening of large uncharacterized pools as performed by that group will inevitably lead to loss of rare, unstable,
or even toxic epitopes present in the original cDNA, thus allowing
detection of common and highly expressed antigens only. In our system,
the use of a sensitive histidine tag-specific staining procedure should
allow detection of any expressed recombinant protein, irrespective of
the actual expression level. The recombinant antigens could be purified
in roughly similar amounts (Fig. 2), but with the band intensities
depending on the individual expression levels. Although most of our
antigens were insoluble under physiological conditions, subsequent
T-cell stimulation assays could be performed with very high
sensitivity. It is very unlikely that putative interactions between
different antigens would affect these assays, because any such
interaction (either specific binding between two peptides or unspecific
aggregation of several molecules) would be broken up during antigen
processing and presentation by APC. In principle, therefore, every
epitope present in our protein library should be available in amounts
sufficient to detect stimulation of proliferation or cytokine
production. Of course, it is conceivable that certain cDNA sequences
cannot be expressed in our bacterial system at all, which is a general
complication with randomly isolated expression clones and applies to
any kind of cDNA library.
Importantly, the fact that in all experiments performed with
preparations of bacteria carrying the empty cloning vector, pEcoK-5, the background values for cell proliferation and IFN-
secretion were
negligible (Fig. 3) argues against contamination with bacterial endotoxin. Using two putatively protective antigens, FABP and calpain,
as controls for our work with murine LN and CD4+ cells, we
detected considerable induction of T-cell proliferation and cytokine
secretion with recombinant calpain only (Fig. 3). This confirmed its
proposed function as a major T-cell antigen in the protective immune
response against schistosome infection. Calpain was the first S. mansoni candidate vaccine identified solely on the basis of its
T-cell reactivity (9), and vaccination with recombinant
calpain resulted in significant immune protection of treated mice
(8). The second control antigen used, FABP, has been
described to be highly protective in mice and rabbits (28),
but all attempts to reproduce these data have failed (reference 3 and our unpublished observations). Because it did
not stimulate detectable levels of lymphocyte proliferation or cytokine
secretion, it was used as a negative control in our experiments.
In order to detect signals from even weakly stimulatory antigens, the
first screening of the protein library was performed with pools
consisting of 12 individual recombinants only. If T-cell stimulation
was observed with a particular pool, the antigens of this pool were
tested individually again. In this way, the whole protein library could
be screened within a short time. However, in assays to determine the
sensitivity of the approach, recombinant calpain induced a significant
IFN-
response even in the presence of a 30- to 100-fold excess of
FABP. This was true not only with a calpain-specific Th1 cell clone
(Fig. 4A) as responder but also with total CD4+ T cells
from the LN of vaccinated mice (Fig. 4B). Since copurification of more
than 12 different antigens could easily be performed (Fig. 2), further
experiments examining 960 cDNA clones purified from 40 pools, each
consisting of 24 cDNA clones, are being performed.
The utility of our new approach to detect T-cell antigens is
demonstrated by the successful identification of a fragment of myosin
heavy chain as the major reactive component in one of the pools tested
(Fig. 5). This result fits with previous data revealing an important
role for myosin in protective immunity against schistosomiasis. A
different fragment of myosin, IrV-5, has been identified by screening a
cDNA library with immune sera (26); however, our myosin
fragment, clone 2.3, does not overlap with IrV-5 except in two amino
acids (Fig. 6). They therefore represent two entirely different parts
of the full-length molecule. Since we were not able to detect clone 2.3 with multiple-vaccination serum, in contrast to the case for
recombinant IrV-5 (Fig. 7), we therefore conclude that clone 2.3 contains a potent T-cell epitope which might never have been identified
by conventional antibody-based screening approaches. Analysis of
additional positive pools of recombinant antigens is under way and will
enable us to identify additional T-cell antigens involved in the immune
reactions in the irradiated vaccine model against schistosomiasis.
However, since protective immunity is directed against lung stage
parasites (6, 16), a cercaria or schistosomulum protein
library, rather than an adult worm library as used for the
above-described experiments, is more likely to allow identification of
potent new vaccine candidates (17) and therefore will
represent an even more important tool for future experiments.
In summary, we believe that by our new approach the technological gap
of an urgently needed efficient method for identifying T-cell antigens
has been filled. The unsatisfactory results from independent trials
with putative vaccine candidates against schistosomiasis (3)
underline the need to pursue new routes for the identification of
antigens other than those predominantly reactive with antibodies.
 |
ACKNOWLEDGMENTS |
This work was supported by a studentship from the Deutsche
Forschungsgemeinschaft (to M.E.) and by a Wellcome Trust Career Development Fellowship (to A.P.M.).
Plasmid pRizk1C was kindly provided by Mette Strand, and recombinant
IrV-5 was kindly provided by Karl Hoffmann. We are grateful to David
Johnston for sequence analysis of cDNA clones for the Schistosoma
Genome Project, to Sonia Anderson for lymphocyte phenotyping, to Pat
Coulson for providing multiple-vaccination serum, and to Boran
Altinçiçek, Ralf Füllkrug, Barbara Preiss, and
Marlene Stein for excellent technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Present address: Department of
Biology, University of York, York YO10 5YW, United Kingdom. Phone: (44) 1904 434387. Fax: (44) 1904 432884. E-mail:
me10{at}york.ac.uk.
Editor:
R. N. Moore
 |
REFERENCES |
| 1.
|
Andresen, K.,
T. D. Tom, and M. Strand.
1991.
Characterization of cDNA clones encoding a novel calcium-activated neutral proteinase from Schistosoma mansoni.
J. Biol. Chem.
266:15085-15090[Abstract/Free Full Text].
|
| 2.
|
Beattie, I. A.,
B. Swaminathan, and H. K. Ziegler.
1990.
Cloning and characterization of T-cell-reactive protein antigens from Listeria monocytogenes.
Infect. Immun.
58:2792-2803[Abstract/Free Full Text].
|
| 3.
|
Bergquist, N. R., and D. G. Colley.
1998.
Schistosomiasis vaccines: research and development.
Parasitol. Today
14:99-104.
|
| 4.
|
Bogdan, C.,
A. Gessner,
W. Solbach, and M. Röllinghoff.
1996.
Invasion, control and persistence of Leishmania parasites.
Curr. Opin. Immunol.
8:517-525[Medline].
|
| 5.
|
Christensen, L. S., and M. Boye.
1992.
Establishment of a genomic bank of bovine herpesvirus 1 using a novel positive selection plasmid vector.
J. Virol. Methods
36:277-282[Medline].
|
| 6.
|
Coulson, P. S.
1997.
The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine?
Adv. Parasitol.
39:271-336[Medline].
|
| 7.
|
De Backer, O.,
P. Chomez, and E. de Plaen.
1994.
Positive selection of recombinant plasmids based on the EcoK restriction activity of Escherichia coli K-12.
Gene
150:197-198[Medline].
|
| 8.
|
Hota-Mitchell, S.,
A. A. Siddiqui,
G. A. Debakan,
J. Smith,
C. Tognon, and R. B. Podesta.
1997.
Protection against Schistosoma mansoni infection with a recombinant baculovirus-expressed subunit of calpain.
Vaccine
15:1631-1640[Medline].
|
| 9.
|
Jankovic, D.,
L. Aslund,
I. P. Oswald,
P. Caspar,
C. Champion,
E. Pearce,
J. E. Coligan,
M. Strand,
A. Sher, and S. L. James.
1996.
Calpain is the target antigen of a Th1 clone that transfers protective immunity against Schistosoma mansoni.
J. Immunol.
157:806-814[Abstract].
|
| 10.
|
Jankovic, D., and A. Sher.
1996.
Initiation and regulation of CD4+ T-cell function in host-parasite models.
Chem. Immunol.
63:51-65[Medline].
|
| 11.
|
Kohlstädt, S.,
P. Couissinier-Paris,
A. Bourgois,
B. Bouchon,
K. Piper,
H. Kolbe, and A. J. Dessein.
1997.
Characterization of a schistosome T cell-stimulating antigen (Sm10) associated with protective immunity in humans.
Mol. Biochem. Parasitol.
84:155-165[Medline].
|
| 12.
|
Liblau, R. S.,
S. M. Singer, and H. O. McDevitt.
1995.
Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.
Immunol. Today
16:34-38[Medline].
|
| 13.
|
Moser, D.,
M. Tendler,
G. Griffiths, and M. Q. Klinkert.
1991.
A 14-kDa Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins.
J. Biol. Chem.
266:8447-8454[Abstract/Free Full Text].
|
| 14.
|
Mougneau, E.,
F. Altare,
A. E. Wakil,
S. Zheng,
T. Coppola,
Z. E. Wang,
R. Waldmann,
R. M. Locksley, and N. Glaichenhaus.
1995.
Expression cloning of a protective Leishmania antigen.
Science
268:563-566[Abstract/Free Full Text].
|
| 15.
|
Mountford, A. P.,
P. S. Coulson,
R. M. Pemberton,
L. E. Smythies, and R. A. Wilson.
1992.
The generation of interferon-gamma-producing T lymphocytes in skin-draining lymph nodes, and their recruitment to the lungs, is associated with protective immunity to Schistosoma mansoni.
Immunology
75:250-256[Medline].
|
| 16.
|
Mountford, A. P.,
R. Harrop, and R. A. Wilson.
1995.
Antigens derived from lung-stage larvae of Schistosoma mansoni are efficient stimulators of proliferation and gamma interferon secretion by lymphocytes from mice vaccinated with irradiated cercariae.
Infect. Immun.
63:1980-1986[Abstract].
|
| 17.
|
Mountford, A. P., and R. Harrop.
1998.
Vaccination against schistosomiasis: the case for lung-stage antigens.
Parasitol. Today
14:109-114.
|
| 18.
|
Mustafa, A. S.,
F. Oftung,
A. Deggerdal,
H. K. Gill,
R. A. Young, and T. Godal.
1988.
Gene isolation with human T lymphocyte probes. Isolation of a gene that expresses an epitope recognized by T cells specific for Mycobacterium bovis BCG and pathogenic mycobacteria.
J. Immunol.
141:2729-2733[Abstract].
|
| 19.
|
Neophytou, P. I.,
B. O. Roep,
S. D. Arden,
E. M. Muir,
G. Duinkerken,
A. Kallan,
R. R. P. de Vries, and J. C. Hutton.
1996.
T-cell epitope analysis using subtracted expression libraries (TEASEL): application to a 38-kDa autoantigen recognized by T cells from an insulin-dependent diabetic patient.
Proc. Natl. Acad. Sci. USA
93:2014-2018[Abstract/Free Full Text].
|
| 20.
|
Saavedra, R.,
F. de Meuter,
J. L. Decourt, and P. Herion.
1991.
Human T cell clone identifies a potentially protective 54-kDa protein antigen of Toxoplasma gondii cloned and expressed in Escherichia coli.
J. Immunol.
147:1975-1982[Abstract].
|
| 21.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 22.
|
Sanderson, S.,
D. J. Campbell, and N. Shastri.
1995.
Identification of a CD4+ T cell-stimulating antigen of pathogenic bacteria by expression cloning.
J. Exp. Med.
182:1752-1757.
|
| 23.
|
Schägger, H., and G. von Jagow.
1987.
Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.
Anal. Biochem.
166:368-379[Medline].
|
| 24.
|
Skeiky, Y. A. W.,
J. A. Guderian,
D. R. Benson,
O. Bacelar,
E. M. Carvalho,
M. Kubin,
R. Badaro,
G. Trinchieri, and S. G. Reed.
1995.
A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.
J. Exp. Med.
181:1527-1537[Abstract/Free Full Text].
|
| 25.
|
Smithers, S. R., and R. J. Terry.
1965.
The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms.
Parasitology
55:695-700[Medline].
|
| 26.
|
Soisson, L. M.,
C. P. Masterson,
T. D. Tom,
M. T. McNally,
G. H. Lowell, and M. Strand.
1992.
Induction of protective immunity in mice using a 62-kDa recombinant fragment of a Schistosoma mansoni surface antigen.
J. Immunol.
149:3612-3620[Abstract].
|
| 27.
|
Stüber, D.,
H. Matile, and G. Garotta.
1990.
System for high level production in E. coli and rapid purification of recombinant proteins: application to epitope mapping, preparation of antibodies and structure-function analysis, p. 121-152.
In
I. Lefkovits, and B. Pernis (ed.), Immunological methods. Academic Press, New York, N.Y.
|
| 28.
|
Tendler, M.,
C. A. Brito,
M. M. Vilar,
N. Serra-Freire,
C. M. Diogo,
M. S. Almeida,
A. C. Delbem,
J. F. da Silva,
W. Savino,
R. C. Garratt,
N. Katz, and A. S. Simpson.
1996.
A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine.
Proc. Natl. Acad. Sci. USA
93:269-273[Abstract/Free Full Text].
|
| 29.
|
Unanue, E. R.
1997.
Studies in listeriosis show the strong symbiosis between the innate cellular system and the T cell response.
Immunol. Rev.
158:11-25[Medline].
|
| 30.
|
Villarreal-Ramos, B.,
J. Sanchez-Garcia,
N. Stoker,
E. Timms,
D. Chomer,
K. Raff, and N. A. Mitchison.
1991.
Screening gene expression libraries for epitopes recognized in Mycobacterium leprae by mouse T cells.
Eur. J. Immunol.
21:2621-2624[Medline].
|
| 31.
|
Warren, R. L.,
D. Lu,
D. R. Sizemore,
L. S. Baron, and D. J. Kopecko.
1990.
Method for identifying microbial antigens that stimulate specific lymphocyte responses: application to Salmonella.
Proc. Natl. Acad. Sci. USA
87:9823-9827[Abstract/Free Full Text].
|
| 32.
|
Waye, M. M. Y.,
M. E. Verhoeyen,
P. T. Jones, and G. Winter.
1985.
EcoK selection vectors for shotgun cloning into M13 and deletion mutagenesis.
Nucleic Acids Res.
13:8561-8571[Abstract/Free Full Text].
|
| 33.
|
Weston, D.,
J. Schmitz,
W. M. Kemp, and W. Kunz.
1993.
Cloning and sequencing of a complete myosin heavy chain cDNA from Schistosoma mansoni.
Mol. Biochem. Parasitol.
58:161-164[Medline].
|
| 34.
|
Wilson, M. E.,
B. M. Young,
K. Paetz Andersen,
J. V. Weinstock,
A. Metwali,
K. M. Ali, and J. E. Donelson.
1995.
A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice.
Infect. Immun.
63:2062-2069[Abstract].
|
Infection and Immunity, July 1999, p. 3383-3389, Vol. 67, No. 7
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Liu, F., Cui, S.-J., Hu, W., Feng, Z., Wang, Z.-Q., Han, Z.-G.
(2009). Excretory/Secretory Proteome of the Adult Developmental Stage of Human Blood Fluke, Schistosoma japonicum. Mol. Cell. Proteomics
8: 1236-1251
[Abstract]
[Full Text]
-
Hooper, S. L., Thuma, J. B.
(2005). Invertebrate Muscles: Muscle Specific Genes and Proteins. Physiol. Rev.
85: 1001-1060
[Abstract]
[Full Text]
-
Eberl, M., Langermans, J. A. M., Frost, P. A., Vervenne, R. A., van Dam, G. J., Deelder, A. M., Thomas, A. W., Coulson, P. S., Wilson, R. A.
(2001). Cellular and Humoral Immune Responses and Protection against Schistosomes Induced by a Radiation-Attenuated Vaccine in Chimpanzees. Infect. Immun.
69: 5352-5362
[Abstract]
[Full Text]
-
Ross, A. G. P., Sleigh, A. C., Li, Y., Davis, G. M., Williams, G. M., Jiang, Z., Feng, Z., McManus, D. P.
(2001). Schistosomiasis in the People's Republic of China: Prospects and Challenges for the 21st Century. Clin. Microbiol. Rev.
14: 270-295
[Abstract]
[Full Text]
-
Boen, E., Crownover, A. R., McIlhaney, M., Korman, A. J., Bill, J.
(2000). Identification of T Cell Ligands in a Library of Peptides Covalently Attached to HLA-DR4. J. Immunol.
165: 2040-2047
[Abstract]
[Full Text]